S2
Market Outlook
14th May, 2015
CHOPPY, VOLATILE DAY WITH A HAPPY ENDING FOR BULLS, NIFTY MAY BE SEEING FIRST SIGN OF BULLISHNESS;
INDEX STILL IN TRADING RANGE – BUY ABOVE 8300, SELL BELOW 8050.



Bank Nifty gets an up day, opened with a gap up of 165 points at 17779.25. Some relief rally was expected after yesterday’s
heavy decline in the index. Trend is sideways in Bank Nifty and it remains sideways till index close above 18900 which will act
as a resistance zone for the index. The charts are not suggesting any trading opportunity as of now. We can also track Nifty’s
chart as it is a wise way to predict movement in Bank nifty for big move. Bank Nifty is trading inside a range of 17500-18900.
Therefore we should avoid the index or trade on the intraday basis till that range breaks. Look for buy on dips and sell on rallies
but with proper stop loss.
CNX IT traded choppy today. The index opened with a gap up and then saw a decline. At the end, prices retraced and closed near
its open. Trend is sideways in this sector and IT Stocks are consolidating. The index is trading inside a range. Support for this
range comes at 10950 whereas resistance comes at 11400. A move beyond these boundaries may give us a trading move in this
sector. As of now, INFY and WIPRO is consolidating and trading inside a narrow range. A breakout in these stocks may give a
buying opportunity.
Intermediate and Short Term Trend is sideways in STEEL Sector. Prices have seen a decline and now finding support at lower
levels. The Sector remained inside its consolidation. SAIL, JSW STEEL and JINDAL STEEL has seen a decline and now
trading near its lower boundary of consolidation. We should avoid trading in these three stocks. TATA STEEL has seen an
upside rally and then went into a narrow range. A breakout in this stock will give us a buying opportunity.
SCRIP
LTP
DESCRIPTION
INFY
1957.6
Short Term Trend is sideways in INFY. The stock has seen a big decline and now consolidating at its
bottom. Prices are in a process of making a bullish head & Shoulder suggest we may see a rally here. Buy
this stock above 1970. If this trade executes then place your stop just below 1930 and a target near 2050.
JUSTDIAL
1076.5
Trend is down in JUSTDIAL. The stock has seen a big decline and went into a consolidation. Prices have
made a bearish pattern of Descending Triangle. A breakdown may give us a shorting opportunity. Sell this
stock below 1070. If this trade executes then place your stop just above 1100 and a target near 1010.
STAR
1013.0
Long Term Trend is up in STAR. Prices have seen a sharp downside move and then went into a
consolidation. Prices find support near 980 and now trading very narrow. Buy this stock above 1025. If this
trade executes then place your stop just below 995 and a target near 1090.
TVSMOTOR
220.5
Trend is down in TVSMOTOR. The stock has seen a minor up move and made a pattern of bearish flag.
Prices have seen a breakdown from this pattern suggests further decline is possible. Sell this stock below
219. If this trade executes then place your stop just above 223 and a target near 211.
FII/DII Data




FIIs net Sell 649.4 Crore rupees shares in Index Future
FIIs net Buy 428.45 Crore rupees shares in Stock Future
FIIs provisionally net Sell 71.2 Crore rupees shares
DIIs provisionally net Buy 254 Crore rupees shares
Key Dates
 WPI Data on 15th May, 2015 (12PM)
Corporate News




MAN Industries has received orders worth approx. Rs. 510 crores from international markets for Oil and Gas sectors.
With these new orders the outstanding executable order book as on date stands approx Rs. 1,300 crores.
Reliance Jio Infocomm has signed an enabling loan of $750 million (Rs 4,800 crore) to fund electronic purchases
from Samsung Electronics and Ace Technologies Corp.
BHEL surpassed its power generation capacity addition target for utilities by 19 percent in 2014-15; BHEL has
commissioned 8,230 MW of utility sets against the target of 6,914 MW for 2014-15.
Suven Life Sciences has been granted one patent each by Europe and Hong Kong for a drug used in the treatment of
neurodegenerative diseases.
Source: Economic Times, Business Standard
Board Meetings
Symbol
Purpose
Meeting Date
Symbol
Purpose
Meeting Date
AHMEDFORGE
Results
14-May-15
ADHUNIK
Results
14-May-15
ARIHANT
Results
14-May-15
INDOTHAI
Results/Dividend
14-May-15
JKTYRE
Trading Window
14-May-15
KOKUYOCMLN
Results/Dividend
14-May-15
JKTYRE
Results/Dividend
14-May-15
MANAPPURAM
Results/Dividend
14-May-15
MONSANTO
Results/Dividend
14-May-15
MANAPPURAM
Results/Dividend
14-May-15
ORIENTBANK
Results/Dividend
14-May-15
ESSARPORTS
Results
14-May-15
AMTEKAUTO
Results
14-May-15
HMVL
Results/Dividend
14-May-15
ABIRLANUVO
Results/Dividend
14-May-15
IMFA
Results/Dividend
14-May-15
JUBLFOOD
Results/Dividend
14-May-15
DALMIASUG
Results/Others
14-May-15
SUBROS
Results/Dividend
14-May-15
NCC
Results/Dividend
14-May-15
AMTEKINDIA
Results
14-May-15
SHARONBIO
Results
14-May-15
HEG
Results/Dividend
14-May-15
ADSL
Results
14-May-15
VIPIND
Results/Dividend
14-May-15
GRAPHITE
Results/Dividend
14-May-15
KKCL
Results/Dividend
14-May-15
PRISMCEM
Results
14-May-15
UTTAMSUGAR
Results/Others
14-May-15
GAMMONIND
Results
14-May-15
APARINDS
Results/Dividend
14-May-15
BARTRONICS
Results
14-May-15
GSFC
Results/Dividend
14-May-15
BLUESTINFO
Results/Dividend
14-May-15
KESARENT
Results
14-May-15
ZYDUSWELL
Results/Dividend
14-May-15
CAREERP
Others
14-May-15
VALUEIND
Results/Others
14-May-15
ARVIND
Trading Window
14-May-15
PCJEWELLER
Results/Dividend
14-May-15
ARVIND
Results/Dividend
14-May-15
ARSHIYA
Results
14-May-15
INDIANB
Results/Dividend
14-May-15
WELINV
Results
14-May-15
OFSS
Results/Dividend
14-May-15
SUBEX
Results
14-May-15
NORBTEAEXP
Results
14-May-15
TTML
Results
14-May-15
MAHABANK
Results/Dividend
14-May-15
DUNCANSLTD
Results
14-May-15
GRINDWELL
Results/Dividend
14-May-15
PALRED
Results
14-May-15
BALKRISIND
Results/Dividend
14-May-15
CASTROLIND
Results
14-May-15
DBCORP
Results/Dividend
14-May-15
DPL
Results
14-May-15
AUSTRAL
Results/Others
14-May-15
SIGNET
Others
14-May-15
Corporate Actions
Security Name
Purpose
Ex Date
Security Name
Purpose
Ex Date
MYSOREBANK
Final Dividend - Rs. - 1.0000
14-May-15
KKALPANAIND
Stock Split From Rs.10/- to Rs.2/-
21-May-15
SBT
Dividend - Rs. - 5.0000
14-May-15
MACK
Right Issue of Equity Shares
21-May-15
ATISHAY
Dividend - Rs. - 0.6000
18-May-15
YESBANK
Final Dividend - Rs. - 9.0000
21-May-15
HIKAL
Interim Dividend - Rs. - 0.5000
18-May-15
CMC
Dividend - Rs. - 27.5000
22-May-15
KHAITANLTD
E-Voting
18-May-15
HARITASEAT
Interim Dividend - Rs. -
22-May-15
SMADL
Stock Split From Rs.10/- to Rs.5/-
18-May-15
KITEX
Dividend - Rs. - 1.2500
25-May-15
NESTLEIND
Final Dividend - Rs. - 12.5000
19-May-15
RELIANCEINF
Dividend - Rs. - 3.5000
26-May-15
NESTLEIND
Interim Dividend - Rs. -
19-May-15
For daily result analysis, follow this link: http://elitestock.com/Research/Result-Analysis
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Advisors Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Advisors
Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making
their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Advisors
Limited are registered/qualified (applied for) as research analysts with SEBI in India.
Disclosure Appendix
Analyst Certification (For Reports)
C SrinivasaKalyan, MBA, M.Com (F&C), MA (Eco), Elite Wealth Advisors Limited, [email protected]
IsrailKhan,Bcom,Elite Wealth Advisors Limited, [email protected]
Raushan Kumar, MBA, Elite Wealth Advisors Limited, [email protected]
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or
their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views
expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Advisors Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer
that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views
expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures,
investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Advisors Limited covered companies by visiting https://www.elitewealth.in, or emailing [email protected] with your request. Elite Wealth Advisors Limited
may screen companies based on Strategy, Technical, and Quantitative
Research. For important disclosures for these companies, please e-mail [email protected].
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk
disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC's website at
https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made
available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Advisors Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst's area of
coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Advisors Limited. Analyst as officer or director: Elite Wealth
Advisors Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any
company in the analyst's area of coverage.
Country Specific Disclosures
India - For private circulation only, not for sale.
Legal Entities Disclosures
Mr. RavinderParkash Seth is the Managing Director of Elite Wealth Advisors Ltd (EWAL, henceforth), having its registered office at S-110, Sahara Mall, M.G. Road,
Gurgaon (Corporate Office-S-8, DDA Shopping Complex, MayurVihar Phase-1, New Delhi-110091), is a SEBI registered Research Analyst (SEBI Registration Number-
applied for) and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWAL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers
research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWAL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWAL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end
of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWAL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public
appearance;
2. Compensation
(a) EWAL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWAL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWAL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject
company in the past twelve months;
(d) EWAL Advisory or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage
services from the subject company in the past twelve months;
(e) EWAL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research
report.
3 In respect of Public Appearances
(a) EWAL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services
provided by EWAL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and
(b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant
banking or brokerage services transactions of the subject company.
(4) EWAL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWAL Advisory has never been engaged in market making activity for the subject company;
(6) EWAL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.
…………………………………………………….